Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity.
Versatope is an immuno-therapeutic company that uses a biotechnology platform to delivery immunity. The company develops a bacterial factory nano particle technology and multiple epitopes can be displayed to overcome strain-specific immunity, enabling biotechnology companies to develop a single vaccine to protect against multiple strains of influenza.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 9, 2020 | Grant | $300K | 1 | — | — | Detail |
Sep 3, 2019 | Funding Round | $193K | — | — | — | Detail |
Sep 26, 2018 | Grant | $17.90M | 1 | — | — | Detail |
May 23, 2017 | Non-Equity Assistant | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Massachusetts Life Sciences Center | — | Grant |
National Institute of Allergy and Infectious Diseases | — | Grant |
MassChallenge | — | Non-Equity Assistant |